A fantastic new study in this issue of Science Translational medicine demonstrates remarkable correlation between a particular combination of blood-borne peptide markers and lung cancer. By evaluating over 300 markers in both patients with benign and cancerous lung legions, the team found 13 markers that were highly predictive of lung cancer.
I first found this article through a mention in GenomeWeb regarding plans to commercialize this and other techniques.
The original article can be found here.
No comments:
Post a Comment